Prostate Cancer - Results from #23680

Clinical development of two innovative pharmaceutical forms of leuprorelin acetate - Abstract March 8, 2013

A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer - Abstract March 8, 2013

Carbogen gas and radiotherapy outcomes in prostate cancer - Abstract March 8, 2013

Prospective evaluation of pentafecta outcomes at 5 years after laparoscopic radical prostatectomy: Results of 170 patients at a single center - Abstract March 8, 2013

Experience with degarelix in the treatment of prostate cancer - Abstract March 8, 2013

A prospective randomized trial: A comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer - March 8, 2013

Metastatic hormone refractory prostate cancer: New treatment horizon - Abstract March 7, 2013

Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer - Abstract March 7, 2013

Electrical impedance spectroscopy for prostate cancer diagnosis - Abstract March 7, 2013

Understanding requirements of novel healthcare information systems for management of advanced prostate cancer - Abstract March 7, 2013

Current role of image-guided robotic radiosurgery (Cyberknife(®) ) for prostate cancer treatment - Abstract March 7, 2013

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer - Abstract March 7, 2013

False-negative bone scan and choline PET/CT study in a case of prostate cancer: The pitfall of the small cell prostate carcinoma variant - Abstract March 7, 2013

Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection - Abstract March 7, 2013

Enzalutamide for the treatment of castration-resistant prostate cancer - Abstract March 6, 2013

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy - Abstract March 6, 2013

A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening - Abstract March 6, 2013

Significance of neoadjuvant hormonal therapy in radical retropubic prostatectomy: A retrospective single-surgeon study - Abstract March 6, 2013

Oxidative stress markers in prostate cancer patients after HDR brachytherapy combined with external beam radiation - Abstract March 6, 2013

Echogenicity in transrectal ultrasound is determined by sound speed of prostate tissue components - Abstract March 6, 2013

Page 1185 of 1436